Literature DB >> 30553909

Frequency of superantigen encoding genes of Staphylococcus aureus isolates collected from multiple sclerosis (MS) patients and nasal carriers.

Javid Sadeghi1, Naser Alizadeh2, Mahin Ahangar Oskouei3, Delara Laghusi4, Daryush Savadi Oskouei5, Masoud Nikanfar6, Mir Naser Seyyed Mousavi7.   

Abstract

BACKGROUND: Bacterial superantigens are potent T cell activators that can have acute or chronic effects on the central nervous system.
OBJECTIVES: In this study, the role of enterotoxins, exfoliative toxins and toxic shock syndrome toxin of Staphylococcus aureus was investigated in MS patients and healthy nasal carriers.
METHODS: Three-hundred fifty nasal swabs were collected from healthy nasal carriers (n = 210) and MS (n = 140) patients. Staphylococcus aureus superantigens were detected by multiplex PCR. Antimicrobial susceptibility pattern was performed using disk diffusion method.
RESULTS: The highest rates of nasal colonization were seen in MS patients (46.42%). The rates of nasal colonization in the healthcare workers were 30.95%. The most commonly detected superantigens were SEA (31.5%), SEB (17.7%) and ETA (16.9%). The Staphylococcus aureus isolates had the highest levels of resistance against erythromycin (57.7%), clindamycin (55.4%) and co-trimoxazole (43.1%). All isolates were susceptible to vancomycin, linezolid, and mupirocin.
CONCLUSION: Our results revealed that the frequency of superantigen producing Staphylococcus aureus isolates is high in the MS patients. As well as these isolates are sensitive to mupirocin. Thus it is better to use of mupirocin for nasal decolonization of Staphylococcus aureus in the MS patients.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Multiple sclerosis; Staphylococcus aureus; Super antigens

Mesh:

Substances:

Year:  2018        PMID: 30553909     DOI: 10.1016/j.micpath.2018.12.010

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  1 in total

1.  Measurement of mucociliary clearance in the patients with multiple sclerosis.

Authors:  Ender Sahin; Mehmet Hamamcı; Yunus Kantekin
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-11-09       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.